Simplex Trading
HAE icon

Simplex Trading’s Haemonetics HAE Stock Holding History

Simplex Trading’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.64K Sell
100
-5,700
-98% -$371K ﹤0.01% 7806
2025
Q4 		$465K Buy
5,800
+100
+2% +$6.72K ﹤0.01% 3373
2025
Q3 		$277K Buy
5,700
+900
+19% +$55.7K ﹤0.01% 4570
2025
Q2 		$358K Sell
4,800
-7,600
-61% -$503K ﹤0.01% 3864
2025
Q1 		$788K Buy
12,400
+9,500
+328% +$646K ﹤0.01% 2938
2024
Q4 		$226K Buy
2,900
+2,000
+222% +$161K ﹤0.01% 4395
2024
Q3 		$72K Sell
900
-7,800
-90% -$630K ﹤0.01% 5536
2024
Q2 		$719K Sell
8,700
-300
-3% -$26.4K ﹤0.01% 3264
2024
Q1 		$768K Sell
9,000
-43,200
-83% -$3.39M ﹤0.01% 3400
2023
Q4 		$4.46M Buy
52,200
+50,800
+3,629% +$4.39M ﹤0.01% 1658
2023
Q3 		$125K Buy
1,400
+1,100
+367% +$98.2K ﹤0.01% 4863
2023
Q2 		$25K Sell
300
-1,800
-86% -$152K ﹤0.01% 6537
2023
Q1 		$173K Sell
2,100
-900
-30% -$72.9K ﹤0.01% 4489
2022
Q4 		$235K Buy
3,000
+2,400
+400% +$193K ﹤0.01% 4029
2022
Q3 		$44K Buy
600
+400
+200% +$28.7K ﹤0.01% 6621
2022
Q2 		$13K Sell
200
-2,200
-92% -$130K ﹤0.01% 8039
2022
Q1 		$151K Sell
2,400
-100
-4% -$5.44K ﹤0.01% 5571
2021
Q4 		$132K Sell
2,500
-18,000
-88% -$1.1M ﹤0.01% 5801
2021
Q3 		$1.39M Hold
20,500
– – ﹤0.01% 2638
2021
Q2 		$1.37M Buy
20,500
+20,498
+1,024,900% +$1.45M ﹤0.01% 2681
2021
Q1 		$22K Buy
2
+1
+100% +$124 ﹤0.01% 7380
2020
Q4 		$11K Sell
1
-183
-99% -$19.7K ﹤0.01% 7345
2020
Q3 		$1.6M Buy
184
+105
+133% +$9.18K ﹤0.01% 1736
2020
Q2 		$707K Sell
79
-80
-50% -$8.08K ﹤0.01% 2478
2020
Q1 		$1.58M Buy
+159
New +$17.2K ﹤0.01% 1475
2019
Q4 		– Sell
-350
Closed -$4.41M – 7538
2019
Q3 		$4.41M Buy
+350
New +$44.4K 0.01% 787
2019
Q2 		– Sell
-16
Closed -$139K – 7372
2019
Q1 		$139K Buy
16
+14
+700% +$1.27K ﹤0.01% 3987
2018
Q4 		$20K Sell
2
-9
-82% -$945 ﹤0.01% 5315
2018
Q3 		$126K Buy
11
+2
+22% +$207 ﹤0.01% 4175
2018
Q2 		$80K Buy
+9
New +$760 ﹤0.01% 4530
2017
Q3 		– Sell
-28
Closed -$6K – 6166
2017
Q2 		$6K Sell
28
-18
-39% -$739 ﹤0.01% 4420
2017
Q1 		$9K Buy
+46
New +$1.8K ﹤0.01% 4052

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Simplex Trading's HAE Position: Q3 2025 in Review

Simplex Trading sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 2,012 shares — an estimated $125K sold.

Simplex Trading first reported a position in HAE in Q3 2018 and held it in 12 quarters. The position peaked at $1.13M in Q2 2022. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Simplex Trading reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 2,012 Haemonetics shares in Q3 2025, an estimated $125K.
  • Simplex Trading first reported a position in Haemonetics in Q3 2018 and held it in 12 quarters.
  • Simplex Trading's Haemonetics position peaked at $1.13M in Q2 2022.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.